Medtronic Announces Strategic Partnership with Cornerstone Robotics

Medtronic has announced an approximately $700 million strategic investment and partnership with Cornerstone Robotics to expand worldwide access to minimally invasive surgical care. The agreement grants Medtronic distribution rights for Cornerstone Robotics' Sentire™ surgical system in select international markets outside the United States where the platform holds market approval, complementing Medtronic's proprietary Hugo™ robotic-assisted surgery (RAS) system.

Context of the Cooperation
Global adoption of robotic-assisted surgery remains in the single digits, presenting a critical growth opportunity to broaden patient and hospital access to advanced surgical platforms. However, healthcare providers face diverse procedural, clinical, and budgetary constraints across various healthcare systems, creating a need for flexible multi-port robotic portfolios rather than single-system offerings.

To address these market and clinical demands, cooperation was established between Medtronic and Cornerstone Robotics. The partnership unites Medtronic’s global commercial footprint, digital surgery infrastructure, and training networks with Cornerstone Robotics’ specialized engineering and in-house platform development. According to Matt Anderson, Senior Vice President and President of Surgical at Medtronic, the investment allows Medtronic to become the only medical device provider delivering a two-platform portfolio combined with a connected digital surgical ecosystem to match varied clinical preferences.

Technical Solution and Responsibilities
The technological framework establishes a complementary multi-port robotic portfolio pairing Medtronic's Hugo RAS system with Cornerstone Robotics' Sentire platform. Responsibilities and technology scopes are allocated across the partners:

Medtronic integrates both platforms into its connected surgical ecosystem, managing international distribution, service, training, and ongoing development for the Hugo RAS system, including Touch Surgery™ digital ecosystem capabilities, real-time AI tools, and integrated stapling.

Cornerstone Robotics designs and manufactures the Sentire system using in-house R&D, supplying the hardware architecture, control software, and dual-console systems.

At a system level, the Sentire platform features an immersive console with dual-console capabilities, offering an ergonomic configuration tailored to diverse surgical specializations. The Hugo RAS system provides a modular, multi-quadrant architecture combining wristed instruments and 3D visualization. Together, the combined systems provide hospitals and surgical teams with flexible operational configurations, scalable procedural footprints, and versatile economic models across varying surgical departments.

Deployment or Implementation
The implementation strategy focuses on commercial deployment across select international markets outside the United States where the Sentire platform has received regulatory clearance. Developed entirely in-house, the Sentire surgical system has completed multi-specialty clinical trials and received CE Mark approval in May 2026 for minimally invasive general, gynecologic, thoracic, and urologic procedures, alongside active market authorizations in China and Singapore.

In parallel, Medtronic continues the global rollout of its Hugo RAS system, which has received U.S. FDA clearance and is currently deployed in more than 35 countries across six continents. Hugo procedure volume is outpacing broader market rates, with cumulative global procedures projected to exceed 50,000 by the end of Medtronic's fiscal year. The joint distribution roadmap leverages Medtronic's established Touch Surgery™ digital ecosystem and training centers to accelerate clinical onboarding and expand robotic adoption across healthcare facilities worldwide.

Edited by Romila DSilva, Induportals Editor, with AI assistance.